Table 2.

Differences in the Pre- and Post-Intravitreal Brolucizumab Injection Variables

Characteristic			Preinjection	Postinjection	P-value
LogMAR BCVA	Entire cohort	Mean (± SD)	0.81 (0.5)	0.66 (0.51)	<0.00001
	Treatment-naïve		0.41 (0.35)	0.36 (0.41)	0.36
	Switch Therapy		0.91 (0.49)	0.73 (0.51)	<0.00001
CST	Entire cohort	Mean (± SD)	408.45 (65.63)	281.14 (37.74)	<0.00001
	Treatment-naïve		398.53 (61.38)	285.16 (15.14)	<0.00001
	Switch Therapy		410.96 (66.42)	280.12 (41.5)	<0.00001

Abbreviations: LogMAR, Logarithm of the Minimum Angle of Resolution; BCVA, Best-corrected visual acuity; SD, Standard deviation; CST, Central subfield thickness.